<!DOCTYPE html>
<!-- saved from url=(0087)https://flask-service-869582453108.asia-east1.run.app/outputs/patent_patent_report.html -->
<html lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
    
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Patent Analysis Report</title>
    <script src="./GLP1_files/mermaid.min.js"></script>
    <script>
        mermaid.initialize({ startOnLoad: false, securityLevel: 'loose', gantt: { axisFormat: "%Y-%m" } });
    </script>
    <style>
        body { font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, "Helvetica Neue", Arial, sans-serif; margin: 20px; background-color: #f8f9fa; color: #333; font-size: 14px;}
        h1 { font-size: 2em; color: #f59e0b; text-align: center; }
        h2 { color: #333; border-bottom: 2px solid #f59e0b; padding-bottom: 5px; margin-top: 40px; }
        .container { width: 100%; overflow-x: auto; margin-bottom: 40px; border: 1px solid #e0e0e0; padding: 10px; border-radius: 8px; background-color: #ffffff; }
        table { width: 100%; border-collapse: collapse; margin-top: 10px; background: #ffffff; border: 1px solid #ddd; }
        th, td { border: 1px solid #ddd; padding: 8px; text-align: left; vertical-align: top; white-space: nowrap; }
        td.wrap-text { white-space: normal; }
        th { background-color: #f2f2f2; font-weight: bold; }
        tr.category-header > td { background-color: #e9ecef; font-weight: bold; font-size: 1.1em; }
        tr.note-row > td { background-color: #fafafa; }
        a { color: #007bff; text-decoration: none; }
        .controls { display: flex; align-items: center; justify-content: space-between; flex-wrap: wrap; margin-bottom: 15px; }
        .controls h2 { margin: 0; border: none; }
        .controls .button-group button { background-color: #f59e0b; color: white; border: none; padding: 8px 12px; border-radius: 4px; cursor: pointer; font-size: 14px; margin-left: 10px; }
        .controls .button-group button:hover { background-color: #e08e0b; }
        .editable-field, textarea.editable-field {
            border: 1px solid transparent; background-color: transparent; width: 100%;
            padding: 2px; margin: 0; font-size: inherit; font-family: inherit;
            color: inherit; cursor: text; box-sizing: border-box; resize: vertical; overflow: hidden;
        }
        .editable-field:focus, textarea.editable-field:focus {
            border: 1px solid #f59e0b; background-color: #fff; outline: none; box-shadow: 0 0 3px rgba(245, 158, 11, 0.5);
        }
    </style>
</head>
<body>
    <h1>PTAxial™</h1>
    <div class="container"><h2>Timeline</h2><div class="mermaid" data-processed="true"><svg id="mermaid-1756455504181" width="100%" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" viewBox="0 0 1414 964" style="max-width: 1414px;" role="graphics-document document" aria-roledescription="gantt"><style>#mermaid-1756455504181{font-family:"trebuchet ms",verdana,arial,sans-serif;font-size:16px;fill:#333;}@keyframes edge-animation-frame{from{stroke-dashoffset:0;}}@keyframes dash{to{stroke-dashoffset:0;}}#mermaid-1756455504181 .edge-animation-slow{stroke-dasharray:9,5!important;stroke-dashoffset:900;animation:dash 50s linear infinite;stroke-linecap:round;}#mermaid-1756455504181 .edge-animation-fast{stroke-dasharray:9,5!important;stroke-dashoffset:900;animation:dash 20s linear infinite;stroke-linecap:round;}#mermaid-1756455504181 .error-icon{fill:#552222;}#mermaid-1756455504181 .error-text{fill:#552222;stroke:#552222;}#mermaid-1756455504181 .edge-thickness-normal{stroke-width:1px;}#mermaid-1756455504181 .edge-thickness-thick{stroke-width:3.5px;}#mermaid-1756455504181 .edge-pattern-solid{stroke-dasharray:0;}#mermaid-1756455504181 .edge-thickness-invisible{stroke-width:0;fill:none;}#mermaid-1756455504181 .edge-pattern-dashed{stroke-dasharray:3;}#mermaid-1756455504181 .edge-pattern-dotted{stroke-dasharray:2;}#mermaid-1756455504181 .marker{fill:#333333;stroke:#333333;}#mermaid-1756455504181 .marker.cross{stroke:#333333;}#mermaid-1756455504181 svg{font-family:"trebuchet ms",verdana,arial,sans-serif;font-size:16px;}#mermaid-1756455504181 p{margin:0;}#mermaid-1756455504181 .mermaid-main-font{font-family:"trebuchet ms",verdana,arial,sans-serif;}#mermaid-1756455504181 .exclude-range{fill:#eeeeee;}#mermaid-1756455504181 .section{stroke:none;opacity:0.2;}#mermaid-1756455504181 .section0{fill:rgba(102, 102, 255, 0.49);}#mermaid-1756455504181 .section2{fill:#fff400;}#mermaid-1756455504181 .section1,#mermaid-1756455504181 .section3{fill:white;opacity:0.2;}#mermaid-1756455504181 .sectionTitle0{fill:#333;}#mermaid-1756455504181 .sectionTitle1{fill:#333;}#mermaid-1756455504181 .sectionTitle2{fill:#333;}#mermaid-1756455504181 .sectionTitle3{fill:#333;}#mermaid-1756455504181 .sectionTitle{text-anchor:start;font-family:"trebuchet ms",verdana,arial,sans-serif;}#mermaid-1756455504181 .grid .tick{stroke:lightgrey;opacity:0.8;shape-rendering:crispEdges;}#mermaid-1756455504181 .grid .tick text{font-family:"trebuchet ms",verdana,arial,sans-serif;fill:#333;}#mermaid-1756455504181 .grid path{stroke-width:0;}#mermaid-1756455504181 .today{fill:none;stroke:red;stroke-width:2px;}#mermaid-1756455504181 .task{stroke-width:2;}#mermaid-1756455504181 .taskText{text-anchor:middle;font-family:"trebuchet ms",verdana,arial,sans-serif;}#mermaid-1756455504181 .taskTextOutsideRight{fill:black;text-anchor:start;font-family:"trebuchet ms",verdana,arial,sans-serif;}#mermaid-1756455504181 .taskTextOutsideLeft{fill:black;text-anchor:end;}#mermaid-1756455504181 .task.clickable{cursor:pointer;}#mermaid-1756455504181 .taskText.clickable{cursor:pointer;fill:#003163!important;font-weight:bold;}#mermaid-1756455504181 .taskTextOutsideLeft.clickable{cursor:pointer;fill:#003163!important;font-weight:bold;}#mermaid-1756455504181 .taskTextOutsideRight.clickable{cursor:pointer;fill:#003163!important;font-weight:bold;}#mermaid-1756455504181 .taskText0,#mermaid-1756455504181 .taskText1,#mermaid-1756455504181 .taskText2,#mermaid-1756455504181 .taskText3{fill:white;}#mermaid-1756455504181 .task0,#mermaid-1756455504181 .task1,#mermaid-1756455504181 .task2,#mermaid-1756455504181 .task3{fill:#8a90dd;stroke:#534fbc;}#mermaid-1756455504181 .taskTextOutside0,#mermaid-1756455504181 .taskTextOutside2{fill:black;}#mermaid-1756455504181 .taskTextOutside1,#mermaid-1756455504181 .taskTextOutside3{fill:black;}#mermaid-1756455504181 .active0,#mermaid-1756455504181 .active1,#mermaid-1756455504181 .active2,#mermaid-1756455504181 .active3{fill:#bfc7ff;stroke:#534fbc;}#mermaid-1756455504181 .activeText0,#mermaid-1756455504181 .activeText1,#mermaid-1756455504181 .activeText2,#mermaid-1756455504181 .activeText3{fill:black!important;}#mermaid-1756455504181 .done0,#mermaid-1756455504181 .done1,#mermaid-1756455504181 .done2,#mermaid-1756455504181 .done3{stroke:grey;fill:lightgrey;stroke-width:2;}#mermaid-1756455504181 .doneText0,#mermaid-1756455504181 .doneText1,#mermaid-1756455504181 .doneText2,#mermaid-1756455504181 .doneText3{fill:black!important;}#mermaid-1756455504181 .crit0,#mermaid-1756455504181 .crit1,#mermaid-1756455504181 .crit2,#mermaid-1756455504181 .crit3{stroke:#ff8888;fill:red;stroke-width:2;}#mermaid-1756455504181 .activeCrit0,#mermaid-1756455504181 .activeCrit1,#mermaid-1756455504181 .activeCrit2,#mermaid-1756455504181 .activeCrit3{stroke:#ff8888;fill:#bfc7ff;stroke-width:2;}#mermaid-1756455504181 .doneCrit0,#mermaid-1756455504181 .doneCrit1,#mermaid-1756455504181 .doneCrit2,#mermaid-1756455504181 .doneCrit3{stroke:#ff8888;fill:lightgrey;stroke-width:2;cursor:pointer;shape-rendering:crispEdges;}#mermaid-1756455504181 .milestone{transform:rotate(45deg) scale(0.8,0.8);}#mermaid-1756455504181 .milestoneText{font-style:italic;}#mermaid-1756455504181 .doneCritText0,#mermaid-1756455504181 .doneCritText1,#mermaid-1756455504181 .doneCritText2,#mermaid-1756455504181 .doneCritText3{fill:black!important;}#mermaid-1756455504181 .vert{stroke:navy;}#mermaid-1756455504181 .vertText{font-size:15px;text-anchor:middle;fill:navy!important;}#mermaid-1756455504181 .activeCritText0,#mermaid-1756455504181 .activeCritText1,#mermaid-1756455504181 .activeCritText2,#mermaid-1756455504181 .activeCritText3{fill:black!important;}#mermaid-1756455504181 .titleText{text-anchor:middle;font-size:18px;fill:#333;font-family:"trebuchet ms",verdana,arial,sans-serif;}#mermaid-1756455504181 :root{--mermaid-font-family:"trebuchet ms",verdana,arial,sans-serif;}</style><g></g><g class="grid" transform="translate(75, 914)" fill="none" font-size="10" font-family="sans-serif" text-anchor="middle"><path class="domain" stroke="currentColor" d="M0,-879V0H1264V-879"></path><g class="tick" opacity="1" transform="translate(28,0)"><line stroke="currentColor" y2="-879"></line><text fill="#000" y="3" dy="1em" stroke="none" font-size="10" style="text-anchor: middle;">2026-01</text></g><g class="tick" opacity="1" transform="translate(191,0)"><line stroke="currentColor" y2="-879"></line><text fill="#000" y="3" dy="1em" stroke="none" font-size="10" style="text-anchor: middle;">2028-01</text></g><g class="tick" opacity="1" transform="translate(354,0)"><line stroke="currentColor" y2="-879"></line><text fill="#000" y="3" dy="1em" stroke="none" font-size="10" style="text-anchor: middle;">2030-01</text></g><g class="tick" opacity="1" transform="translate(518,0)"><line stroke="currentColor" y2="-879"></line><text fill="#000" y="3" dy="1em" stroke="none" font-size="10" style="text-anchor: middle;">2032-01</text></g><g class="tick" opacity="1" transform="translate(681,0)"><line stroke="currentColor" y2="-879"></line><text fill="#000" y="3" dy="1em" stroke="none" font-size="10" style="text-anchor: middle;">2034-01</text></g><g class="tick" opacity="1" transform="translate(844,0)"><line stroke="currentColor" y2="-879"></line><text fill="#000" y="3" dy="1em" stroke="none" font-size="10" style="text-anchor: middle;">2036-01</text></g><g class="tick" opacity="1" transform="translate(1008,0)"><line stroke="currentColor" y2="-879"></line><text fill="#000" y="3" dy="1em" stroke="none" font-size="10" style="text-anchor: middle;">2038-01</text></g><g class="tick" opacity="1" transform="translate(1171,0)"><line stroke="currentColor" y2="-879"></line><text fill="#000" y="3" dy="1em" stroke="none" font-size="10" style="text-anchor: middle;">2040-01</text></g></g><g><rect x="0" y="888" width="1376.5" height="24" class="section section3"></rect><rect x="0" y="48" width="1376.5" height="24" class="section section0"></rect><rect x="0" y="72" width="1376.5" height="24" class="section section0"></rect><rect x="0" y="96" width="1376.5" height="24" class="section section0"></rect><rect x="0" y="120" width="1376.5" height="24" class="section section0"></rect><rect x="0" y="144" width="1376.5" height="24" class="section section0"></rect><rect x="0" y="168" width="1376.5" height="24" class="section section0"></rect><rect x="0" y="432" width="1376.5" height="24" class="section section1"></rect><rect x="0" y="192" width="1376.5" height="24" class="section section0"></rect><rect x="0" y="216" width="1376.5" height="24" class="section section0"></rect><rect x="0" y="240" width="1376.5" height="24" class="section section0"></rect><rect x="0" y="264" width="1376.5" height="24" class="section section0"></rect><rect x="0" y="288" width="1376.5" height="24" class="section section0"></rect><rect x="0" y="312" width="1376.5" height="24" class="section section0"></rect><rect x="0" y="336" width="1376.5" height="24" class="section section0"></rect><rect x="0" y="456" width="1376.5" height="24" class="section section1"></rect><rect x="0" y="480" width="1376.5" height="24" class="section section2"></rect><rect x="0" y="504" width="1376.5" height="24" class="section section2"></rect><rect x="0" y="528" width="1376.5" height="24" class="section section2"></rect><rect x="0" y="552" width="1376.5" height="24" class="section section2"></rect><rect x="0" y="360" width="1376.5" height="24" class="section section0"></rect><rect x="0" y="576" width="1376.5" height="24" class="section section2"></rect><rect x="0" y="600" width="1376.5" height="24" class="section section2"></rect><rect x="0" y="624" width="1376.5" height="24" class="section section2"></rect><rect x="0" y="648" width="1376.5" height="24" class="section section2"></rect><rect x="0" y="384" width="1376.5" height="24" class="section section0"></rect><rect x="0" y="744" width="1376.5" height="24" class="section section3"></rect><rect x="0" y="672" width="1376.5" height="24" class="section section2"></rect><rect x="0" y="696" width="1376.5" height="24" class="section section2"></rect><rect x="0" y="768" width="1376.5" height="24" class="section section3"></rect><rect x="0" y="792" width="1376.5" height="24" class="section section3"></rect><rect x="0" y="816" width="1376.5" height="24" class="section section3"></rect><rect x="0" y="408" width="1376.5" height="24" class="section section0"></rect><rect x="0" y="840" width="1376.5" height="24" class="section section3"></rect><rect x="0" y="720" width="1376.5" height="24" class="section section2"></rect><rect x="0" y="864" width="1376.5" height="24" class="section section3"></rect></g><g><rect id="task36" rx="3" ry="3" x="75" y="890" width="0" height="20" transform-origin="75px 900px" class="task active3 "></rect><rect id="task1" rx="3" ry="3" x="87" y="50" width="0" height="20" transform-origin="87px 60px" class="task active0 "></rect><rect id="task2" rx="3" ry="3" x="107" y="74" width="1" height="20" transform-origin="107.5px 84px" class="task active0 "></rect><rect id="task3" rx="3" ry="3" x="107" y="98" width="1" height="20" transform-origin="107.5px 108px" class="task active0 "></rect><rect id="task4" rx="3" ry="3" x="107" y="122" width="1" height="20" transform-origin="107.5px 132px" class="task active0 "></rect><rect id="task5" rx="3" ry="3" x="107" y="146" width="1" height="20" transform-origin="107.5px 156px" class="task active0 "></rect><rect id="task6" rx="3" ry="3" x="107" y="170" width="1" height="20" transform-origin="107.5px 180px" class="task active0 "></rect><rect id="task17" rx="3" ry="3" x="120" y="434" width="1" height="20" transform-origin="120.5px 444px" class="task active1 "></rect><rect id="task7" rx="3" ry="3" x="147" y="194" width="1" height="20" transform-origin="147.5px 204px" class="task active0 "></rect><rect id="task8" rx="3" ry="3" x="147" y="218" width="1" height="20" transform-origin="147.5px 228px" class="task active0 "></rect><rect id="task9" rx="3" ry="3" x="147" y="242" width="1" height="20" transform-origin="147.5px 252px" class="task active0 "></rect><rect id="task10" rx="3" ry="3" x="160" y="266" width="0" height="20" transform-origin="160px 276px" class="task active0 "></rect><rect id="task11" rx="3" ry="3" x="168" y="290" width="0" height="20" transform-origin="168px 300px" class="task active0 "></rect><rect id="task12" rx="3" ry="3" x="236" y="314" width="1" height="20" transform-origin="236.5px 324px" class="task active0 "></rect><rect id="task13" rx="3" ry="3" x="245" y="338" width="0" height="20" transform-origin="245px 348px" class="task active0 "></rect><rect id="task18" rx="3" ry="3" x="505" y="458" width="1" height="20" transform-origin="505.5px 468px" class="task active1 "></rect><rect id="task19" rx="3" ry="3" x="589" y="482" width="1" height="20" transform-origin="589.5px 492px" class="task active2 "></rect><rect id="task20" rx="3" ry="3" x="589" y="506" width="1" height="20" transform-origin="589.5px 516px" class="task active2 "></rect><rect id="task21" rx="3" ry="3" x="589" y="530" width="1" height="20" transform-origin="589.5px 540px" class="task active2 "></rect><rect id="task22" rx="3" ry="3" x="589" y="554" width="1" height="20" transform-origin="589.5px 564px" class="task active2 "></rect><rect id="task14" rx="3" ry="3" x="600" y="362" width="0" height="20" transform-origin="600px 372px" class="task active0 "></rect><rect id="task23" rx="3" ry="3" x="691" y="578" width="1" height="20" transform-origin="691.5px 588px" class="task active2 "></rect><rect id="task24" rx="3" ry="3" x="691" y="602" width="1" height="20" transform-origin="691.5px 612px" class="task active2 "></rect><rect id="task25" rx="3" ry="3" x="691" y="626" width="1" height="20" transform-origin="691.5px 636px" class="task active2 "></rect><rect id="task26" rx="3" ry="3" x="691" y="650" width="1" height="20" transform-origin="691.5px 660px" class="task active2 "></rect><rect id="task15" rx="3" ry="3" x="713" y="386" width="0" height="20" transform-origin="713px 396px" class="task active0 "></rect><rect id="task30" rx="3" ry="3" x="713" y="746" width="0" height="20" transform-origin="713px 756px" class="task active3 "></rect><rect id="task27" rx="3" ry="3" x="783" y="674" width="1" height="20" transform-origin="783.5px 684px" class="task active2 "></rect><rect id="task28" rx="3" ry="3" x="783" y="698" width="1" height="20" transform-origin="783.5px 708px" class="task active2 "></rect><rect id="task31" rx="3" ry="3" x="1135" y="770" width="1" height="20" transform-origin="1135.5px 780px" class="task active3 "></rect><rect id="task32" rx="3" ry="3" x="1135" y="794" width="1" height="20" transform-origin="1135.5px 804px" class="task active3 "></rect><rect id="task33" rx="3" ry="3" x="1135" y="818" width="1" height="20" transform-origin="1135.5px 828px" class="task active3 "></rect><rect id="task16" rx="3" ry="3" x="1146" y="410" width="1" height="20" transform-origin="1146.5px 420px" class="task active0 "></rect><rect id="task34" rx="3" ry="3" x="1146" y="842" width="1" height="20" transform-origin="1146.5px 852px" class="task active3 "></rect><rect id="task29" rx="3" ry="3" x="1171" y="722" width="1" height="20" transform-origin="1171.5px 732px" class="task active2 "></rect><rect id="task35" rx="3" ry="3" x="1338" y="866" width="1" height="20" transform-origin="1338.5px 876px" class="task active3 "></rect><text id="task36-text" font-size="11" x="80" y="903.5" text-height="20" class=" taskTextOutsideRight taskTextOutside3 activeText3 width-28.24721908569336">Today </text><text id="task1-text" font-size="11" x="92" y="63.5" text-height="20" class=" taskTextOutsideRight taskTextOutside0 activeText0 width-64.77717590332031">US8684969B2 </text><text id="task2-text" font-size="11" x="113" y="87.5" text-height="20" class=" taskTextOutsideRight taskTextOutside0 activeText0 width-70.53992462158203">US10376652B2 </text><text id="task3-text" font-size="11" x="113" y="111.5" text-height="20" class=" taskTextOutsideRight taskTextOutside0 activeText0 width-64.77717590332031">US9616180B2 </text><text id="task4-text" font-size="11" x="113" y="135.5" text-height="20" class=" taskTextOutsideRight taskTextOutside0 activeText0 width-64.77717590332031">US9108002B2 </text><text id="task5-text" font-size="11" x="113" y="159.5" text-height="20" class=" taskTextOutsideRight taskTextOutside0 activeText0 width-70.53992462158203">US10357616B2 </text><text id="task6-text" font-size="11" x="113" y="183.5" text-height="20" class=" taskTextOutsideRight taskTextOutside0 activeText0 width-64.77717590332031">US9861757B2 </text><text id="task17-text" font-size="11" x="126" y="447.5" text-height="20" class=" taskTextOutsideRight taskTextOutside1 activeText1 width-64.77717590332031">US8536122B2 </text><text id="task7-text" font-size="11" x="153" y="207.5" text-height="20" class=" taskTextOutsideRight taskTextOutside0 activeText0 width-64.77716827392578">US8920383B2 </text><text id="task8-text" font-size="11" x="153" y="231.5" text-height="20" class=" taskTextOutsideRight taskTextOutside0 activeText0 width-70.53990936279297">US10220155B2 </text><text id="task9-text" font-size="11" x="153" y="255.5" text-height="20" class=" taskTextOutsideRight taskTextOutside0 activeText0 width-70.53990936279297">US11097063B2 </text><text id="task10-text" font-size="11" x="165" y="279.5" text-height="20" class=" taskTextOutsideRight taskTextOutside0 activeText0 width-64.77717590332031">US8114833B2 </text><text id="task11-text" font-size="11" x="173" y="303.5" text-height="20" class=" taskTextOutsideRight taskTextOutside0 activeText0 width-64.77717590332031">US9775953B2 </text><text id="task12-text" font-size="11" x="242" y="327.5" text-height="20" class=" taskTextOutsideRight taskTextOutside0 activeText0 width-64.77717590332031">US9687611B2 </text><text id="task13-text" font-size="11" x="250" y="351.5" text-height="20" class=" taskTextOutsideRight taskTextOutside0 activeText0 width-64.77717590332031">US9457154B2 </text><text id="task18-text" font-size="11" x="511" y="471.5" text-height="20" class=" taskTextOutsideRight taskTextOutside1 activeText1 width-64.77717590332031">US8129343B2 </text><text id="task19-text" font-size="11" x="595" y="495.5" text-height="20" class=" taskTextOutsideRight taskTextOutside2 activeText2 width-70.53996276855469">US10960052B2 </text><text id="task20-text" font-size="11" x="595" y="519.5" text-height="20" class=" taskTextOutsideRight taskTextOutside2 activeText2 width-64.77721405029297">US9278123B2 </text><text id="task21-text" font-size="11" x="595" y="543.5" text-height="20" class=" taskTextOutsideRight taskTextOutside2 activeText2 width-70.53996276855469">US10086047B2 </text><text id="task22-text" font-size="11" x="595" y="567.5" text-height="20" class=" taskTextOutsideRight taskTextOutside2 activeText2 width-70.53996276855469">US11382957B2 </text><text id="task14-text" font-size="11" x="605" y="375.5" text-height="20" class=" taskTextOutsideRight taskTextOutside0 activeText0 width-64.77713775634766">US9132239B2 </text><text id="task23-text" font-size="11" x="697" y="591.5" text-height="20" class=" taskTextOutsideRight taskTextOutside2 activeText2 width-70.53992462158203">US11759503B2 </text><text id="task24-text" font-size="11" x="697" y="615.5" text-height="20" class=" taskTextOutsideRight taskTextOutside2 activeText2 width-70.53992462158203">US11759502B2 </text><text id="task25-text" font-size="11" x="697" y="639.5" text-height="20" class=" taskTextOutsideRight taskTextOutside2 activeText2 width-70.53992462158203">US11759501B2 </text><text id="task26-text" font-size="11" x="697" y="663.5" text-height="20" class=" taskTextOutsideRight taskTextOutside2 activeText2 width-70.53992462158203">US10933120B2 </text><text id="task15-text" font-size="11" x="718" y="399.5" text-height="20" class=" taskTextOutsideRight taskTextOutside0 activeText0 width-70.53992462158203">US10335462B2 </text><text id="task30-text" font-size="11" x="718" y="759.5" text-height="20" class=" taskTextOutsideRight taskTextOutside3 activeText3 width-64.77717590332031">US9764003B2 </text><text id="task27-text" font-size="11" x="789" y="687.5" text-height="20" class=" taskTextOutsideRight taskTextOutside2 activeText2 width-70.53992462158203">US10278923B2 </text><text id="task28-text" font-size="11" x="789" y="711.5" text-height="20" class=" taskTextOutsideRight taskTextOutside2 activeText2 width-70.53992462158203">US12239739B2 </text><text id="task31-text" font-size="11" x="1141" y="783.5" text-height="20" class=" taskTextOutsideRight taskTextOutside3 activeText3 width-70.53992462158203">US12214017B2 </text><text id="task32-text" font-size="11" x="1141" y="807.5" text-height="20" class=" taskTextOutsideRight taskTextOutside3 activeText3 width-70.53992462158203">US11752198B2 </text><text id="task33-text" font-size="11" x="1141" y="831.5" text-height="20" class=" taskTextOutsideRight taskTextOutside3 activeText3 width-70.53992462158203">US10888605B2 </text><text id="task16-text" font-size="11" x="1152" y="423.5" text-height="20" class=" taskTextOutsideRight taskTextOutside0 activeText0 width-70.53992462158203">US12295988B2 </text><text id="task34-text" font-size="11" x="1152" y="855.5" text-height="20" class=" taskTextOutsideRight taskTextOutside3 activeText3 width-70.53992462158203">US12029779B2 </text><text id="task29-text" font-size="11" x="1177" y="735.5" text-height="20" class=" taskTextOutsideRight taskTextOutside2 activeText2 width-70.53992462158203">US11833248B2 </text><text id="task35-text" font-size="11" x="1333" y="879.5" text-height="20" class=" taskTextOutsideLeft taskTextOutside3 activeText3">US11318191B2 </text></g><g><text dy="0em" x="10" y="242" font-size="11" class="sectionTitle sectionTitle0"><tspan alignment-baseline="central" x="10">Ozempic</tspan></text><text dy="0em" x="10" y="458" font-size="11" class="sectionTitle sectionTitle1"><tspan alignment-baseline="central" x="10">Ozempic, Wegovy, Rybelsus</tspan></text><text dy="0em" x="10" y="614" font-size="11" class="sectionTitle sectionTitle2"><tspan alignment-baseline="central" x="10">Rybelsus</tspan></text><text dy="0em" x="10" y="830" font-size="11" class="sectionTitle sectionTitle3"><tspan alignment-baseline="central" x="10">Wegovy</tspan></text></g><g class="today"><line x1="75" x2="75" y1="25" y2="939" class="today" style="stroke:red;stroke-width:2px"></line></g><text x="707" y="25" class="titleText">Patent Expiry Timeline</text></svg></div></div>
    <div class="container">
        <div class="controls">
            <h2>Patent Table</h2>
            <div class="button-group">
                <button onclick="exportSelectedDataToCSV()" title="只匯出打勾的項目，方便分享與局部處理">匯出已勾選項目</button>
                <button onclick="exportFullVersionToCSV()" title="匯出整份報告的當前狀態，作為新版本存檔">匯出完整版本 (另存新檔)</button>
                <button onclick="document.getElementById(&#39;fileInput&#39;).click()">載入資料</button>
                <input type="file" id="fileInput" style="display: none;" onchange="loadDataFromCSV(event)" accept=".csv">
            </div>
        </div>
        <table id="patent-data-table">
            <thead>
                <tr>
                    <th style="width: 40px;"><input type="checkbox" id="select-all-checkbox" title="全選/取消全選"></th>
                    <th style="min-width: 180px;">Patent Number</th>
                    <th style="min-width: 300px;">Title</th>
                    <th style="min-width: 150px;">Category</th>
                    <th style="min-width: 200px;">Technology Tag</th>
                    <th style="min-width: 200px;">Efficacy Tag</th>
                    <th style="min-width: 120px;">Expiry Date</th>
                    <th style="min-width: 120px;">PTA Extension</th>
                </tr>
            </thead>
            <tbody>
<tr class="category-header"><td colspan="8"><strong>Ozempic</strong></td></tr>
        <tr data-patent-number="US10376652B2">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/US10376652B2" target="_blank">US10376652B2</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 38px;">Automatic injection device with a top release mechanism</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="Ozempic"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="member"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="medical upper mechanical"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value="2026-01-20"></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="ck"></td>
        </tr>
        <tr class="note-row" data-patent-number="US10376652B2">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="US10376652B2">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2017-02-24">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="False">
                <input type="hidden" class="editable-field" data-column="Abstract" value="The present invention relates to a handheld mechanical injection device by which set doses of a liquid medicament can be injected from a medical reservoir. The medicament is expelled through an injection needle by release of a power reservoir in the device, the power reservoir being fully or partially released by actuation of a user operable release member being positioned at or near an upper end of the injection device, the upper end being that end of the injection device which is opposite the injection needle.">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 38px;">Device</textarea></td>
        </tr>
    
        <tr data-patent-number="US9616180B2">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/US9616180B2" target="_blank">US9616180B2</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 38px;">Automatic injection device with a top release mechanism</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="Ozempic"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="device"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="medical upper mechanical"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value="2026-01-20"></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="ck"></td>
        </tr>
        <tr class="note-row" data-patent-number="US9616180B2">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="US9616180B2">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2015-07-13">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="False">
                <input type="hidden" class="editable-field" data-column="Abstract" value="The present invention relates to a handheld mechanical injection device by which set doses of a liquid medicament can be injected from a medical reservoir. The medicament is expelled through an injection needle by release of a power reservoir in the device, the power reservoir being fully or partially released by actuation of a user operable release member being positioned at or near an upper end of the injection device, the upper end being that end of the injection device which is opposite the injection needle.">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 38px;">Device</textarea></td>
        </tr>
    
        <tr data-patent-number="US9108002B2">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/US9108002B2" target="_blank">US9108002B2</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 38px;">Automatic injection device with a top release mechanism</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="Ozempic"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="device"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="medical upper mechanical"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value="2026-01-20"></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="ck"></td>
        </tr>
        <tr class="note-row" data-patent-number="US9108002B2">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="US9108002B2">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2011-12-15">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="False">
                <input type="hidden" class="editable-field" data-column="Abstract" value="The present invention relates to a handheld mechanical injection device by which set doses of a liquid medicament can be injected from a medical reservoir. The medicament is expelled through an injection needle by release of a power reservoir in the device, the power reservoir being fully or partially released by actuation of a user operable release member being positioned at or near an upper end of the injection device, the upper end being that end of the injection device which is opposite the injection needle.">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 38px;">Device</textarea></td>
        </tr>
    
        <tr data-patent-number="US9132239B2">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/US9132239B2" target="_blank">US9132239B2</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 21px;">Dial-down mechanism for wind-up pen</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="Ozempic"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="surface device"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="reduce act move"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value="2032-02-01"></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="Adjusted"></td>
        </tr>
        <tr class="note-row" data-patent-number="US9132239B2">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="US9132239B2">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2009-10-21">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="False">
                <input type="hidden" class="editable-field" data-column="Abstract" value="The present invention relates to a dial-down mechanism for an injection device comprising a torsion spring for assisting injection of a dose of medicament from the injection device, the dial-down mechanism comprising a ratchet arm (21) engaging a ring element (10) and a reset element (30) which acts on a knob located on the periphery of the ratchet arm (21) to move the ratchet arm (21) out of engagement with the ring element (10) in order to allow the set dose to be reduced.">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 38px;">Device</textarea></td>
        </tr>
    
        <tr data-patent-number="US9775953B2">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/US9775953B2" target="_blank">US9775953B2</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 55px;">Dose mechanism for an injection device for limiting a dose setting corresponding to the amount of medicament left</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="Ozempic"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="rod"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="thread move"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value="2026-10-17"></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="Adjusted"></td>
        </tr>
        <tr class="note-row" data-patent-number="US9775953B2">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="US9775953B2">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2014-11-21">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="False">
                <input type="hidden" class="editable-field" data-column="Abstract" value="A mechanism for preventing setting of a dose, which exceeds the amount of a medicament in a reservoir in an injection device. The device can contain a threaded piston rod, a limiter and a driver. The three elements can be arranged such that during dose setting, the limiter is moved towards an end-of-content position, wherein dose setting is limited. The invention contains an accumulative and a non-accumulative embodiment. The invention further relates to a mechanism for preventing ejection of a dose exceeding the set dose.">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 38px;">Device</textarea></td>
        </tr>
    
        <tr data-patent-number="US8920383B2">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/US8920383B2" target="_blank">US8920383B2</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 55px;">Dose mechanism for an injection device for limiting a dose setting corresponding to the amount of medicament left</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="Ozempic"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="reservoir"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="thread move"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value="2026-07-17"></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="ck"></td>
        </tr>
        <tr class="note-row" data-patent-number="US8920383B2">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="US8920383B2">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2006-07-17">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="False">
                <input type="hidden" class="editable-field" data-column="Abstract" value="A mechanism for preventing setting of a dose, which exceeds the amount of a medicament in a reservoir in an injection device. The device comprises a threaded piston rod, a limiter and a driver. The three elements are arranged such that during dose setting, the limiter is moved towards an end-of-contend position, wherein dose setting is limited. The invention comprises an accumulative and a non-accumulative embodiment. The invention further relates to a mechanism for prevention ejection of a dose exceeding the set dose.">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 38px;">Device</textarea></td>
        </tr>
    
        <tr data-patent-number="US10357616B2">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/US10357616B2" target="_blank">US10357616B2</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 38px;">Injection device with an end of dose feedback mechanism</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="Ozempic"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="part"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="cause engage build"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value="2026-01-20"></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="ck"></td>
        </tr>
        <tr class="note-row" data-patent-number="US10357616B2">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="US10357616B2">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2017-11-17">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="False">
                <input type="hidden" class="editable-field" data-column="Abstract" value="An injection device with a dose delivering mechanism being adapted to provide a non-visual, e.g. audible and/or tactile, feedback signal when a set dose has been at least substantially injected. A first and a second part of the injection device are adapted to perform a relative rotational movement with respect to each other. The relative rotational movement causes at least two parts of the injection device to abut or engage, and this abutment or engagement causes the non-visual feedback signal to be generated. A very distinct and precise feedback is provided as compared to prior art axial solutions because the generation of the feedback signal is initiated by the relative rotational movement.Feedback signal may be generated by a change in a rotational velocity of at least one part, e.g. by changing the pitch of a threaded portion or by engaging a non-rotating part and a rotating part, thereby causing the non-rotating part to start rotating. May alternatively be generated by building up and releasing a tension.The injection device is suitable for injecting insulin.">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 38px;">Device</textarea></td>
        </tr>
    
        <tr data-patent-number="US9861757B2">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/US9861757B2" target="_blank">US9861757B2</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 38px;">Injection device with an end of dose feedback mechanism</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="Ozempic"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="signal"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="cause engage build"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value="2026-01-20"></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="ck"></td>
        </tr>
        <tr class="note-row" data-patent-number="US9861757B2">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="US9861757B2">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2016-08-19">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="False">
                <input type="hidden" class="editable-field" data-column="Abstract" value="An injection device with a dose delivering mechanism being adapted to provide a non-visual, e.g. audible and/or tactile, feedback signal when a set dose has been at least substantially injected. A first and a second part of the injection device are adapted to perform a relative rotational movement with respect to each other. The relative rotational movement causes at least two parts of the injection device to abut or engage, and this abutment or engagement causes the non-visual feedback signal to be generated. A very distinct and precise feedback is provided as compared to prior art axial solutions because the generation of the feedback signal is initiated by the relative rotational movement.Feedback signal may be generated by a change in a rotational velocity of at least one part, e.g. by changing the pitch of a threaded portion or by engaging a non-rotating part and a rotating part, thereby causing the non-rotating part to start rotating. May alternatively be generated by building up and releasing a tension.The injection device is suitable for injecting insulin.">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 38px;">Device</textarea></td>
        </tr>
    
        <tr data-patent-number="US9457154B2">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/US9457154B2" target="_blank">US9457154B2</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 38px;">Injection device with an end of dose feedback mechanism</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="Ozempic"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="signal"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="cause engage build"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value="2027-09-27"></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="Adjusted"></td>
        </tr>
        <tr class="note-row" data-patent-number="US9457154B2">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="US9457154B2">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2006-01-20">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="False">
                <input type="hidden" class="editable-field" data-column="Abstract" value="An injection device with a dose delivering mechanism being adapted to provide a non-visual, e.g. audible and/or tactile, feedback signal when a set dose has been at least substantially injected. A first and a second part of the injection device are adapted to perform a relative rotational movement with respect to each other. The relative rotational movement causes at least two parts of the injection device to abut or engage, and this abutment or engagement causes the non-visual feedback signal to be generated. A very distinct and precise feedback is provided as compared to prior art axial solutions because the generation of the feedback signal is initiated by the relative rotational movement. Feedback signal may be generated by a change in a rotational velocity of at least one part, e.g. by changing the pitch of a threaded portion or by engaging a non-rotating part and a rotating part, thereby causing the non-rotating part to start rotating. May alternatively be generated by building up and releasing a tension. The injection device is suitable for injecting insulin.">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 38px;">Device</textarea></td>
        </tr>
    
        <tr data-patent-number="US9687611B2">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/US9687611B2" target="_blank">US9687611B2</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 38px;">Injection device with torsion spring and rotatable display</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="Ozempic"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="device"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="arrange adapt helical"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value="2027-08-21"></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="ck"></td>
        </tr>
        <tr class="note-row" data-patent-number="US9687611B2">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="US9687611B2">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2014-01-29">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="False">
                <input type="hidden" class="editable-field" data-column="Abstract" value="The present invention relates to an injection device comprising a torsion spring operatively connected to a dose setting member being adapted to set a dose to be ejected from the injection device. A rotatably mounted display member adapted to display the dose to be ejected in accordance with a setting of the dose setting member is also provided. The rotatably mounted display member is adapted to be rotated over an angle corresponding to at least one revolution of the display member. The display member may be implemented as a dose indicator barrel having numerals arranged along a helical path on an outer surface thereof, or alternatively, as a counting device having two or more display wheels having numerals arranged on an outer surface thereof.">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 38px;">Device</textarea></td>
        </tr>
    
        <tr data-patent-number="US8684969B2">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/US8684969B2" target="_blank">US8684969B2</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 38px;">Injection device with torsion spring and rotatable display</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="Ozempic"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="device"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="arrange adapt helical"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value="2025-10-20"></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="ck"></td>
        </tr>
        <tr class="note-row" data-patent-number="US8684969B2">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="US8684969B2">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2012-09-25">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="False">
                <input type="hidden" class="editable-field" data-column="Abstract" value="The present invention relates to an injection device comprising a torsion spring operatively connected to a dose setting member being adapted to set a dose to be ejected from the injection device. A rotatably mounted display member adapted to display the dose to be ejected in accordance with a setting of the dose setting member is also provided. The rotatably mounted display member is adapted to be rotated over an angle corresponding to at least one revolution of the display member. The display member may be implemented as a dose indicator barrel having numerals arranged along a helical path on an outer surface thereof, or alternatively, as a counting device having two or more display wheels having numerals arranged on an outer surface thereof.">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 38px;">Device</textarea></td>
        </tr>
    
        <tr data-patent-number="US8114833B2">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/US8114833B2" target="_blank">US8114833B2</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 55px;">Propylene glycol-containing peptide formulations which are optimal for production and for use in injection devices</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="Ozempic"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="PEG content"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="injectable composition"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value="2026-09-12"></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="Adjusted"></td>
        </tr>
        <tr class="note-row" data-patent-number="US8114833B2">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="US8114833B2">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2006-05-17">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="False">
                <input type="hidden" class="editable-field" data-column="Abstract" value="The present invention relates to pharmaceutical formulations comprising a peptide and propylene glycol, to methods of preparing such formulations, and to uses of such formulations in the treatment of diseases and conditions for which use of the peptide contained in such formulations is indicated. The present invention further relates to methods for reducing the clogging of injection devices by a peptide formulation and for reducing deposits on production equipment during production of a peptide formulation.">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 55px;">disodium phosphate dihydrate buffer and propylene glycol, wherein said propylene glycol is present in said formulation in a final concentration of from about 1 mg/ml to about 100 mg/ml and wherein said formulation has a pH of from about 7.0 to about 10.0.
</textarea></td>
        </tr>
    
        <tr data-patent-number="US12295988B2">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/US12295988B2" target="_blank">US12295988B2</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 21px;">Semaglutide in medical therapy</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="Ozempic"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="weekly 2.0 mg"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="type 2 diabetes"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value="2038-10-10"></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="ck"></td>
        </tr>
        <tr class="note-row" data-patent-number="US12295988B2">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="US12295988B2">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2024-08-30">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="False">
                <input type="hidden" class="editable-field" data-column="Abstract" value="The present invention relates to semaglutide for use in weight management.">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 38px;">MOU</textarea></td>
        </tr>
    
        <tr data-patent-number="US11097063B2">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/US11097063B2" target="_blank">US11097063B2</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 55px;">Syringe device with a dose limiting mechanism and an additional safety mechanism</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="Ozempic"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="dose"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="exceed fail prevent eject"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value="2026-07-17"></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="ck"></td>
        </tr>
        <tr class="note-row" data-patent-number="US11097063B2">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="US11097063B2">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2019-01-17">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="False">
                <input type="hidden" class="editable-field" data-column="Abstract" value="A syringe device for ejecting a dose of a medicament, the syringe device comprising: a dose limiting mechanism arranged to interact with a dose ejecting mechanism to prevent ejection of a dose exceeding a set dose, and a safety mechanism, which is arranged such with respect to the dose ejecting mechanism that, if the dose limiting mechanism fails, the safety mechanism prevents ejection of a dose exceeding the set dose.">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 38px;">Device</textarea></td>
        </tr>
    
        <tr data-patent-number="US10220155B2">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/US10220155B2" target="_blank">US10220155B2</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 55px;">Syringe device with a dose limiting mechanism and an additional safety mechanism</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="Ozempic"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="dose"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="exceed fail prevent eject"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value="2026-07-17"></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="ck"></td>
        </tr>
        <tr class="note-row" data-patent-number="US10220155B2">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="US10220155B2">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2006-07-17">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="False">
                <input type="hidden" class="editable-field" data-column="Abstract" value="A syringe device for ejecting a dose of a medicament, the syringe device comprising: a dose limiting mechanism arranged to interact with a dose ejecting mechanism to prevent ejection of a dose exceeding a set dose, and a safety mechanism, which is arranged such with respect to the dose ejecting mechanism that, if the dose limiting mechanism fails, the safety mechanism prevents ejection of a dose exceeding the set dose.">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 38px;">Device</textarea></td>
        </tr>
    
        <tr data-patent-number="US10335462B2">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/US10335462B2" target="_blank">US10335462B2</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 21px;">Use of long-acting GLP-1 peptides</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="Ozempic"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="Weekly 1.0 mg"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="type 2 diabetes"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value="2033-06-21"></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="ck"></td>
        </tr>
        <tr class="note-row" data-patent-number="US10335462B2">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="US10335462B2">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2017-07-21">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="False">
                <input type="hidden" class="editable-field" data-column="Abstract" value="The invention relates to use of long-acting GLP-1 peptides in certain dosage regimes for the treatment of type 2 diabetes, obesity, etc.">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 38px;">MOU</textarea></td>
        </tr>
    <tr class="category-header"><td colspan="8"><strong>Ozempic, Wegovy, Rybelsus</strong></td></tr>
        <tr data-patent-number="US8536122B2">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/US8536122B2" target="_blank">US8536122B2</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 21px;">Acylated GLP-1 compounds</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="Ozempic, Wegovy, Rybelsus"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="Compound"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="new molecule"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value="2026-03-20"></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="Adjusted"></td>
        </tr>
        <tr class="note-row" data-patent-number="US8536122B2">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="US8536122B2">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2012-03-05">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="False">
                <input type="hidden" class="editable-field" data-column="Abstract" value="Protracted GLP-1 compounds and therapeutic uses thereof.">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 38px;">new protracted GLP-1 compounds</textarea></td>
        </tr>
    
        <tr data-patent-number="US8129343B2">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/US8129343B2" target="_blank">US8129343B2</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 21px;">Acylated GLP-1 compounds</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="Ozempic, Wegovy, Rybelsus"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="ethoxy"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="new molecule"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value="2030-12-06"></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="Adjusted"></td>
        </tr>
        <tr class="note-row" data-patent-number="US8129343B2">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="US8129343B2">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2006-03-20">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="False">
                <input type="hidden" class="editable-field" data-column="Abstract" value="Protracted GLP-1 compounds and therapeutic uses thereof.">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 38px;">NEP inhibitor </textarea></td>
        </tr>
    <tr class="category-header"><td colspan="8"><strong>Rybelsus</strong></td></tr>
        <tr data-patent-number="US11759503B2">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/US11759503B2" target="_blank">US11759503B2</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 38px;">Compositions of GLP-1 peptides and preparation thereof</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="Rybelsus"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="granule"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="caprylic salt"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value="2033-03-15"></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="nan"></td>
        </tr>
        <tr class="note-row" data-patent-number="US11759503B2">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="US11759503B2">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2022-04-13">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="False">
                <input type="hidden" class="editable-field" data-column="Abstract" value="The invention relates to pharmaceutical compositions comprising a first type of granules and a second type of granules, wherein said first type of granules comprises a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid and no GLP-1 peptide, and wherein said second type of granules comprises a GLP-1 peptide and no salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid, as well as the intermediate granules, processes for the preparation of the granules and compositions, and use thereof in medicine.">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 38px;">(a) a first type of granules comprising at least 75% (w/w) of sodium N-(8-(2-hydroxybenzoyl)amino)caprylic acid (SNAC) and less than 10% (w/w) of a lubricant; and
(b) a second type of granules comprising semaglutide, at least 15% (w/w) of a filler, and less than 40% (w/w) of a binder.</textarea></td>
        </tr>
    
        <tr data-patent-number="US11759502B2">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/US11759502B2" target="_blank">US11759502B2</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 38px;">Compositions of GLP-1 peptides and preparation thereof</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="Rybelsus"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="granule"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="caprylic salt"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value="2033-03-15"></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="nan"></td>
        </tr>
        <tr class="note-row" data-patent-number="US11759502B2">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="US11759502B2">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2022-04-13">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="False">
                <input type="hidden" class="editable-field" data-column="Abstract" value="The invention relates to pharmaceutical compositions comprising a first type of granules and a second type of granules, wherein said first type of granules comprises a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid and no GLP-1 peptide, and wherein said second type of granules comprises a GLP-1 peptide and no salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid, as well as the intermediate granules, processes for the preparation of the granules and compositions, and use thereof in medicine.">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 71px;">(1) a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid (salt of NAC) and (2) a granule;
wherein the granule comprises semaglutide, a binder, a filler, and no salt of NAC;
wherein the filler is at least 15% (w/w) of the granule; and
wherein the binder is less than 40% (w/w) of the granule.</textarea></td>
        </tr>
    
        <tr data-patent-number="US11759501B2">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/US11759501B2" target="_blank">US11759501B2</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 38px;">Compositions of GLP-1 peptides and preparation thereof</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="Rybelsus"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="granule"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="caprylic salt"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value="2033-03-15"></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="nan"></td>
        </tr>
        <tr class="note-row" data-patent-number="US11759501B2">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="US11759501B2">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2021-01-25">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="False">
                <input type="hidden" class="editable-field" data-column="Abstract" value="The invention relates to pharmaceutical compositions comprising a first type of granules and a second type of granules, wherein said first type of granules comprises a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid and no GLP-1 peptide, and wherein said second type of granules comprises a GLP-1 peptide and no salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid, as well as the intermediate granules, processes for the preparation of the granules and compositions, and use thereof in medicine.">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 71px;">(1) semaglutide and (2) a granule;
wherein the granule comprises a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid (salt of NAC), a lubricant, and no semaglutide;
wherein the salt of NAC is at least 75% (w/w) of the granule; and
wherein the lubricant is less than 10% (w/w) of the granule.</textarea></td>
        </tr>
    
        <tr data-patent-number="US10933120B2">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/US10933120B2" target="_blank">US10933120B2</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 38px;">Compositions of GLP-1 peptides and preparation thereof</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="Rybelsus"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="ethoxy"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="caprylic salt"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value="2033-03-15"></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="nan"></td>
        </tr>
        <tr class="note-row" data-patent-number="US10933120B2">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="US10933120B2">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2013-03-15">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="False">
                <input type="hidden" class="editable-field" data-column="Abstract" value="The invention relates to pharmaceutical compositions comprising a first type of granules and a second type of granules, wherein said first type of granules comprises a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid and no GLP-1 peptide, and wherein said second type of granules comprises a GLP-1 peptide and no salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid, as well as the intermediate granules, processes for the preparation of the granules and compositions, and use thereof in medicine.">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 122px;">(a) a first type of granules comprising sodium N-(8-(2-hydroxybenzoyl)amino)caprylic acid (SNAC), lubricant, and no GLP-1 peptide, wherein the SNAC is at least 75% (w/w), and wherein the lubricant is less than 10% (w/w);
(b) a second type of granules comprising GLP-1 peptide, filler, binder, and no SNAC, wherein the GLP-1 peptide is 2 to 40% (w/w), wherein the filler is at least 15% (w/w), and wherein the binder is less than 40% (w/w); wherein:
the GLP-1 peptide is semaglutide, wherein the formula of semaglutide is N-epsilon26-[2-(2-{2-[2-(2-{2-[(S)-4-carboxy-4-(17-carboxy-heptadecanoylamino)butyrylamino]ethoxy}ethoxy)acetylamino]ethoxy}ethoxy)acetyl] [Aib8,Arg34]GLP-1(7-37); and
the composition is a tablet, wherein the weight of the tablet is in the range of 150 mg to 1000 mg.</textarea></td>
        </tr>
    
        <tr data-patent-number="US12239739B2">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/US12239739B2" target="_blank">US12239739B2</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 21px;">Oral dosing of GLP-1 compounds</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="Rybelsus"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="snac"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="type 2 diabetes and/or reducing body weight"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value="2034-05-02"></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="nan"></td>
        </tr>
        <tr class="note-row" data-patent-number="US12239739B2">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="US12239739B2">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2019-03-22">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="False">
                <input type="hidden" class="editable-field" data-column="Abstract" value="The present invention relates to improved uses of glucagon-like peptide-1 (GLP-1) peptides in oral therapy.">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 38px;">orally administering to the subject a therapeutically effective amount of a solid oral dosage form composition comprising a glucagon-like peptide-1 (GLP-1) peptide and an enhancer,</textarea></td>
        </tr>
    
        <tr data-patent-number="US10278923B2">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/US10278923B2" target="_blank">US10278923B2</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 21px;">Oral dosing of GLP-1 compounds</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="Rybelsus"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="ethoxy"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="type 2 diabetes and/or reducing body weight"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value="2034-05-02"></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="nan"></td>
        </tr>
        <tr class="note-row" data-patent-number="US10278923B2">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="US10278923B2">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2017-07-17">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="False">
                <input type="hidden" class="editable-field" data-column="Abstract" value="The present invention relates to improved uses of GLP-1 peptides in oral therapy.">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 38px;">solid oral dosage form composition</textarea></td>
        </tr>
    
        <tr data-patent-number="US10960052B2">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/US10960052B2" target="_blank">US10960052B2</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 55px;">Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl) amino) caprylic acid</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="Rybelsus"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="cellulose"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="caprylic salt"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value="2031-12-16"></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="nan"></td>
        </tr>
        <tr class="note-row" data-patent-number="US10960052B2">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="US10960052B2">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2018-08-30">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="False">
                <input type="hidden" class="editable-field" data-column="Abstract" value="The present invention relates to solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid and their use in medicine.">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 38px;">wherein the composition comprises at least 60% (w/w) of said salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid.</textarea></td>
        </tr>
    
        <tr data-patent-number="US11833248B2">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/US11833248B2" target="_blank">US11833248B2</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 55px;">Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="Rybelsus"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="sodium diabete"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="hydroxybenzoyl amino caprylic acid"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value="2039-02-01"></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="nan"></td>
        </tr>
        <tr class="note-row" data-patent-number="US11833248B2">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="US11833248B2">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2019-09-13">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="False">
                <input type="hidden" class="editable-field" data-column="Abstract" value="The invention relates to pharmaceutical compositions comprising a peptide, such as a GLP-1 peptide and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid. The invention further relates to processes for the preparation of such compositions, and their use in medicine.">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 38px;">"consisting essentially of"</textarea></td>
        </tr>
    
        <tr data-patent-number="US11382957B2">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/US11382957B2" target="_blank">US11382957B2</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 55px;">Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="Rybelsus"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="filler"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="caprylic salt"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value="2031-12-16"></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="nan"></td>
        </tr>
        <tr class="note-row" data-patent-number="US11382957B2">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="US11382957B2">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2021-02-19">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="False">
                <input type="hidden" class="editable-field" data-column="Abstract" value="The present invention relates to solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid and their use in medicine.">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 38px;">solid composition for oral administration
wherein the composition comprises at least 60% (w/w) of the salt of N-(8-(2-hydroxybenzyol)amino)caprylic acid.</textarea></td>
        </tr>
    
        <tr data-patent-number="US10086047B2">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/US10086047B2" target="_blank">US10086047B2</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 55px;">Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="Rybelsus"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="ethoxy"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="caprylic salt"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value="2031-12-16"></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="nan"></td>
        </tr>
        <tr class="note-row" data-patent-number="US10086047B2">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="US10086047B2">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2016-02-09">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="False">
                <input type="hidden" class="editable-field" data-column="Abstract" value="The present invention relates to solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid and their use in medicine.">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 38px;">solid pharmaceutical composition for oral administration
composition has surface eroding or co-release properties, and a disintegration time of 7-15 minutes.</textarea></td>
        </tr>
    
        <tr data-patent-number="US9278123B2">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/US9278123B2" target="_blank">US9278123B2</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 55px;">Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="Rybelsus"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="ethoxy"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="caprylic salt"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value="2031-12-16"></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="nan"></td>
        </tr>
        <tr class="note-row" data-patent-number="US9278123B2">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="US9278123B2">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2011-12-16">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="False">
                <input type="hidden" class="editable-field" data-column="Abstract" value="The present invention relates to solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid and their use in medicine.">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 38px;">salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid</textarea></td>
        </tr>
    <tr class="category-header"><td colspan="8"><strong>Wegovy</strong></td></tr>
        <tr data-patent-number="US12214017B2">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/US12214017B2" target="_blank">US12214017B2</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 21px;">GLP-1 compositions and uses thereof</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="Wegovy"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="phenol-free"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="Stable composition"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value="2038-08-24"></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="nan"></td>
        </tr>
        <tr class="note-row" data-patent-number="US12214017B2">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="US12214017B2">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2024-01-30">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="False">
                <input type="hidden" class="editable-field" data-column="Abstract" value="The present invention relates to pharmaceutical compositions of the GLP-1 peptide semaglutide comprising no more than 0.01% (w/w) phenol, their preparation, kits comprising such compositions as well as uses thereof.">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 122px;">liquid pharmaceutical composition
(a) does not contain phenol; and
(b) is administered parenterally; and
(c)(i) is an aqueous solution comprising at least 60% (w/w) water or (ii)
further comprises one or more pharmaceutically acceptable excipients selected from the group consisting of a buffer or an isotonic agent; and
wherein the semaglutide is in the range of 0.01 mg/ml-10.0 mg/ml; and
wherein the pH of the composition is in between 7.0 and 7.8.</textarea></td>
        </tr>
    
        <tr data-patent-number="US11752198B2">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/US11752198B2" target="_blank">US11752198B2</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 21px;">GLP-1 compositions and uses thereof</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="Wegovy"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="solution buffer group"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="Stable composition"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value="2038-08-24"></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="nan"></td>
        </tr>
        <tr class="note-row" data-patent-number="US11752198B2">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="US11752198B2">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2020-12-08">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="False">
                <input type="hidden" class="editable-field" data-column="Abstract" value="The present invention relates to pharmaceutical compositions of the GLP-1 peptide semaglutide comprising no more than 0.01% (w/w) phenol, their preparation, kits comprising such compositions as well as uses thereof.">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 71px;">liquid pharmaceutical composition
does not contain phenol;
is for parenteral administration;
is an aqueous solution comprising at least 60% (w/w) water; or</textarea></td>
        </tr>
    
        <tr data-patent-number="US11318191B2">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/US11318191B2" target="_blank">US11318191B2</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 21px;">GLP-1 compositions and uses thereof</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="Wegovy"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="buffer"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="Stable composition"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value="2041-02-17"></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="nan"></td>
        </tr>
        <tr class="note-row" data-patent-number="US11318191B2">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="US11318191B2">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2021-02-17">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="False">
                <input type="hidden" class="editable-field" data-column="Abstract" value="The present invention relates to pharmaceutical compositions of the GLP-1 peptide semaglutide comprising no more than 0.1% (w/w) phenol and above 6.4 mg/ml sodium chloride, their preparation, kits comprising such compositions as well as uses thereof.">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 71px;">liquid pharmaceutical composition
0.5 to 10 mg/mL semaglutide,
0.0% (w/w) to 0.1% (w/w) phenol, and
8.2 to 8.9 mg/mL sodium chloride.</textarea></td>
        </tr>
    
        <tr data-patent-number="US10888605B2">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/US10888605B2" target="_blank">US10888605B2</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 21px;">GLP-1 compositions and uses thereof</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="Wegovy"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="phenol limited"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="Stable composition"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value="2038-08-24"></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="nan"></td>
        </tr>
        <tr class="note-row" data-patent-number="US10888605B2">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="US10888605B2">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2020-01-28">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="False">
                <input type="hidden" class="editable-field" data-column="Abstract" value="The present invention relates to pharmaceutical compositions of the GLP-1 peptide semaglutide comprising no more than 0.01% (w/w) phenol, their preparation, kits comprising such compositions as well as uses thereof.">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 71px;">liquid pharmaceutical composition
wherein the semaglutide is in the range of 0.5 mg/ml-5.0 mg/ml;
wherein the phenol is no more than 0.1 mg/ml; and
wherein the pH of the composition is in between 7.0 and 7.8.</textarea></td>
        </tr>
    
        <tr data-patent-number="US12029779B2">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/US12029779B2" target="_blank">US12029779B2</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 21px;">Semaglutide in medical therapy</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="Wegovy"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="weekly 2.4mg"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="reducing body weight"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value="2038-10-10"></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="nan"></td>
        </tr>
        <tr class="note-row" data-patent-number="US12029779B2">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="US12029779B2">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2020-04-09">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="False">
                <input type="hidden" class="editable-field" data-column="Abstract" value="The present invention relates to semaglutide for use in weight management.">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 38px;">administering semaglutide subcutaneously to the subject in an amount of about 2.4 mg weekly.
</textarea></td>
        </tr>
    
        <tr data-patent-number="US9764003B2">
            <td><input type="checkbox" class="export-checkbox"></td>
            <td><a href="https://patents.google.com/patent/US9764003B2" target="_blank">US9764003B2</a></td>
            <td class="wrap-text"><textarea rows="1" class="editable-field" data-column="Title" style="height: 21px;">Use of long-acting GLP-1 peptides</textarea></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Category" value="Wegovy"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Technology Tag" value="weekly 0.7 to 1.6 mg"></td>
            <td class="wrap-text"><input type="text" class="editable-field" data-column="Efficacy Tag" value="reducing body weight"></td>
            <td><input type="text" class="editable-field" data-column="Expiry Date" value="2033-06-21"></td>
            <td><input type="text" class="editable-field" data-column="PTA Extension" value="nan"></td>
        </tr>
        <tr class="note-row" data-patent-number="US9764003B2">
            <td style="display:none;">
                <input type="hidden" class="editable-field" data-column="Patent Number" value="US9764003B2">
                <input type="hidden" class="editable-field" data-column="Classification Tag" value="nan">
                <input type="hidden" class="editable-field" data-column="Application Date" value="2013-06-21">
                <input type="hidden" class="editable-field" data-column="Is Terminal Disclaimer" value="False">
                <input type="hidden" class="editable-field" data-column="Abstract" value="The invention relates to use of long-acting GLP-1 peptides in certain dosage regimes for the treatment of type 2 diabetes, obesity, etc.">
            </td>
            <td></td>
            <td colspan="7"><textarea rows="2" class="editable-field" data-column="Note" placeholder="點此輸入註解..." style="height: 38px;">long-acting GLP-1</textarea></td>
        </tr>
    </tbody></table></div><div class="container"><h2>2-D Matrix: Category vs. Efficacy</h2><table><thead><tr><th>Category / Efficacy</th><th>Stable composition</th><th>arrange adapt helical</th><th>caprylic salt</th><th>cause engage build</th><th>exceed fail prevent eject</th><th>hydroxybenzoyl amino caprylic acid</th><th>injectable composition</th><th>medical upper mechanical</th><th>new molecule</th><th>reduce act move</th><th>reducing body weight</th><th>thread move</th><th>type 2 diabetes</th><th>type 2 diabetes and/or reducing body weight</th></tr></thead><tbody><tr><td>Ozempic</td><td></td><td class="wrap-text"><a href="https://patents.google.com/patent/US9687611B2" target="_blank">US9687611B2</a>, <a href="https://patents.google.com/patent/US8684969B2" target="_blank">US8684969B2</a></td><td></td><td class="wrap-text"><a href="https://patents.google.com/patent/US10357616B2" target="_blank">US10357616B2</a>, <a href="https://patents.google.com/patent/US9861757B2" target="_blank">US9861757B2</a>, <a href="https://patents.google.com/patent/US9457154B2" target="_blank">US9457154B2</a></td><td class="wrap-text"><a href="https://patents.google.com/patent/US11097063B2" target="_blank">US11097063B2</a>, <a href="https://patents.google.com/patent/US10220155B2" target="_blank">US10220155B2</a></td><td></td><td class="wrap-text"><a href="https://patents.google.com/patent/US8114833B2" target="_blank">US8114833B2</a></td><td class="wrap-text"><a href="https://patents.google.com/patent/US10376652B2" target="_blank">US10376652B2</a>, <a href="https://patents.google.com/patent/US9616180B2" target="_blank">US9616180B2</a>, <a href="https://patents.google.com/patent/US9108002B2" target="_blank">US9108002B2</a></td><td></td><td class="wrap-text"><a href="https://patents.google.com/patent/US9132239B2" target="_blank">US9132239B2</a></td><td></td><td class="wrap-text"><a href="https://patents.google.com/patent/US9775953B2" target="_blank">US9775953B2</a>, <a href="https://patents.google.com/patent/US8920383B2" target="_blank">US8920383B2</a></td><td class="wrap-text"><a href="https://patents.google.com/patent/US12295988B2" target="_blank">US12295988B2</a>, <a href="https://patents.google.com/patent/US10335462B2" target="_blank">US10335462B2</a></td><td></td></tr><tr><td>Ozempic, Wegovy, Rybelsus</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td class="wrap-text"><a href="https://patents.google.com/patent/US8536122B2" target="_blank">US8536122B2</a>, <a href="https://patents.google.com/patent/US8129343B2" target="_blank">US8129343B2</a></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Rybelsus</td><td></td><td></td><td class="wrap-text"><a href="https://patents.google.com/patent/US11759503B2" target="_blank">US11759503B2</a>, <a href="https://patents.google.com/patent/US11759502B2" target="_blank">US11759502B2</a>, <a href="https://patents.google.com/patent/US11759501B2" target="_blank">US11759501B2</a>, <a href="https://patents.google.com/patent/US10933120B2" target="_blank">US10933120B2</a>, <a href="https://patents.google.com/patent/US10960052B2" target="_blank">US10960052B2</a>, <a href="https://patents.google.com/patent/US11382957B2" target="_blank">US11382957B2</a>, <a href="https://patents.google.com/patent/US10086047B2" target="_blank">US10086047B2</a>, <a href="https://patents.google.com/patent/US9278123B2" target="_blank">US9278123B2</a></td><td></td><td></td><td class="wrap-text"><a href="https://patents.google.com/patent/US11833248B2" target="_blank">US11833248B2</a></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td class="wrap-text"><a href="https://patents.google.com/patent/US12239739B2" target="_blank">US12239739B2</a>, <a href="https://patents.google.com/patent/US10278923B2" target="_blank">US10278923B2</a></td></tr><tr><td>Wegovy</td><td class="wrap-text"><a href="https://patents.google.com/patent/US12214017B2" target="_blank">US12214017B2</a>, <a href="https://patents.google.com/patent/US11752198B2" target="_blank">US11752198B2</a>, <a href="https://patents.google.com/patent/US11318191B2" target="_blank">US11318191B2</a>, <a href="https://patents.google.com/patent/US10888605B2" target="_blank">US10888605B2</a></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td class="wrap-text"><a href="https://patents.google.com/patent/US12029779B2" target="_blank">US12029779B2</a>, <a href="https://patents.google.com/patent/US9764003B2" target="_blank">US9764003B2</a></td><td></td><td></td><td></td></tr></tbody></table></div>
    <footer><p>© 2025 Eudaimonia IP Consulting. All rights reserved.</p></footer>
<script>
    // This script block contains all the final, working Javascript functions.
    // (JavaScript is unchanged from the last working version)
    function autoResizeTextarea(element) { element.style.height = 'auto'; element.style.height = (element.scrollHeight) + 'px'; }
    function setupEventListeners() {
        try { mermaid.run({ querySelector: ".mermaid" }); } catch(e) { console.error("Mermaid Error:", e); }
        var selectAllCheckbox = document.getElementById('select-all-checkbox');
        var itemCheckboxes = document.querySelectorAll('#patent-data-table .export-checkbox');
        if(selectAllCheckbox) {
            selectAllCheckbox.addEventListener('change', function() { itemCheckboxes.forEach(function(c) { c.checked = selectAllCheckbox.checked; }); });
        }
        itemCheckboxes.forEach(function(checkbox) {
            checkbox.addEventListener('change', function() {
                if (!checkbox.checked) { selectAllCheckbox.checked = false; }
                else { selectAllCheckbox.checked = Array.from(itemCheckboxes).every(function(cb) { return cb.checked; }); }
            });
        });
        document.querySelectorAll('textarea.editable-field').forEach(function(textarea) {
            textarea.addEventListener('input', function() { autoResizeTextarea(this); });
            autoResizeTextarea(textarea);
        });
    }
    if (document.readyState === 'loading') { document.addEventListener('DOMContentLoaded', setupEventListeners); } else { setupEventListeners(); }
    function sanitizeCell(cellData) { var data = String(cellData == null ? '' : cellData); if (/[",\r\n]/.test(data)) { return '"' + data.replace(/"/g, '""') + '"'; } return data; }
    function gatherRowData(dataRow) {
        var noteRow = dataRow.nextElementSibling;
        var rowData = {};
        [...dataRow.querySelectorAll('.editable-field'), ...(noteRow ? noteRow.querySelectorAll('.editable-field') : [])].forEach(function(field) {
             rowData[field.dataset.column] = field.value; 
        });
        return rowData;
    }
    function downloadCSV(csvContent, filename) {
        if (!csvContent) { alert("沒有資料可供匯出。"); return; }
        var blob = new Blob(['\uFEFF' + csvContent], { type: 'text/csv;charset=utf-8;' });
        var link = document.createElement("a");
        var url = URL.createObjectURL(blob);
        link.setAttribute("href", url); link.setAttribute("download", filename);
        document.body.appendChild(link); link.click();
        document.body.removeChild(link); URL.revokeObjectURL(url);
    }
    function exportSelectedDataToCSV() {
        var headers = ['Patent Number', 'Title', 'Classification Tag', 'Category', 'Application Date', 'Expiry Date', 'Is Terminal Disclaimer', 'Technology Tag', 'Efficacy Tag', 'Abstract', 'PTA Extension', 'Note'];
        var csvRows = [headers.join(',')];
        var checkedBoxes = document.querySelectorAll('#patent-data-table .export-checkbox:checked');
        if (checkedBoxes.length === 0) { alert("請先勾選您想要匯出的專利項目。"); return; }
        checkedBoxes.forEach(function(checkbox) {
            var dataRow = checkbox.closest('tr');
            var rowData = gatherRowData(dataRow);
            var orderedRow = headers.map(function(header) { return rowData[header] || ""; });
            csvRows.push(orderedRow.map(sanitizeCell).join(','));
        });
        downloadCSV(csvRows.join('\n'), "patent_data_selected.csv");
        alert("成功匯出 " + checkedBoxes.length + " 筆已勾選的專利資料！");
    }
    function exportFullVersionToCSV() {
        var headers = ['Patent Number', 'Title', 'Classification Tag', 'Category', 'Application Date', 'Expiry Date', 'Is Terminal Disclaimer', 'Technology Tag', 'Efficacy Tag', 'Abstract', 'PTA Extension', 'Note'];
        var csvRows = [headers.join(',')];
        var allDataRows = document.querySelectorAll('#patent-data-table > tbody > tr:not(.category-header):not(.note-row)');
        if (allDataRows.length === 0) { alert("表格中沒有找到任何資料可供匯出。"); return; }
        allDataRows.forEach(function(dataRow) {
            var rowData = gatherRowData(dataRow);
            var orderedRow = headers.map(function(header) { return rowData[header] || ""; });
            csvRows.push(orderedRow.map(sanitizeCell).join(','));
        });
        downloadCSV(csvRows.join('\n'), "patent_data_full_version.csv");
        alert("成功匯出 " + allDataRows.length + " 筆完整專利資料！");
    }
    function loadDataFromCSV(event) {
        var file = event.target.files[0]; if (!file) return;
        var reader = new FileReader();
        reader.onload = function(e) {
            var lines = e.target.result.split(/\r?\n/);
            var recordsUpdated = 0;
            var headers = lines[0].split(',').map(function(h) { return h.trim().replace(/"/g, '').toLowerCase(); });
            var patentIdIndex = headers.indexOf('patent number');
            if (patentIdIndex === -1) { alert("CSV 檔案中找不到 'Patent Number' 欄位。"); event.target.value = ''; return; }
            var headerMap = {};
            headers.forEach(function(h, i) { headerMap[h] = i; });
            for (var i = 1; i < lines.length; i++) {
                var line = lines[i]; if (line.trim() === '') continue;
                var columns = line.match(/(".*?"|[^",]+)(?=\s*,|\s*$)/g) || [];
                var patentId = (columns[patentIdIndex] || '').trim().replace(/^"|"$/g, '');
                if (patentId) {
                    var escapedPatentId = patentId.replace(/"/g, '\"');
                    var dataRow = document.querySelector(`tr[data-patent-number="${escapedPatentId}"]`);
                    if(dataRow) {
                        var noteRow = dataRow.nextElementSibling;
                        var fields = [...dataRow.querySelectorAll('.editable-field'), ...(noteRow ? noteRow.querySelectorAll('.editable-field') : [])];
                        fields.forEach(function(field) {
                            var columnKey = field.dataset.column.toLowerCase();
                            var columnIndex = headerMap[columnKey];
                            if (columnIndex !== undefined && columns[columnIndex] !== undefined) {
                                var value = columns[columnIndex].trim().replace(/^"|"$/g, '').replace(/""/g, '"');
                                field.value = value;
                            }
                        });
                        [...dataRow.querySelectorAll('textarea.editable-field'), ...(noteRow ? noteRow.querySelectorAll('textarea.editable-field') : [])].forEach(autoResizeTextarea);
                        recordsUpdated++;
                    }
                }
            }
            alert("處理完成！共更新了 " + recordsUpdated + " 筆專利的資料。");
            event.target.value = '';
        };
        reader.readAsText(file, 'UTF-8');
    }
</script>


</body></html>